moxalactam has been researched along with cefoxitin in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 64 (78.05) | 18.7374 |
1990's | 1 (1.22) | 18.2507 |
2000's | 12 (14.63) | 29.6817 |
2010's | 5 (6.10) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
Aubert, D; Naas, T; Nordmann, P; Ozcan, A | 1 |
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Doi, Y; Nordmann, P; Paterson, DL; Poirel, L | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
Girlich, D; Nordmann, P; Poirel, L | 2 |
Freimer, EH; Ingalls, CS | 1 |
Deguchi, K; Fukayama, S; Fukushima, Y; Koguchi, M; Nakane, Y; Nishimura, Y; Oda, S; Sato, K; Tanaka, S; Yokota, N | 1 |
Avril, JL; Donnio, PY; Lebert, P; Travert, MF | 1 |
Wilson, SE | 2 |
Heizmann, W; Luft, G; Werner, H | 1 |
Goldstein, NH | 1 |
Gall, SA; Gibbs, RS; Hemsell, DL; Knuppel, RA; Lane, TW; Miller, RD; Newton, ER; Poindexter, AN; Reguero, W; Sweet, RL | 1 |
Boswick, JA; Duma, RJ; Echols, RM; Jemsek, JG; Lerner, R; Lewis, RT; Najem, AZ; Press, RA; Rittenbury, MS; Wilson, SE | 1 |
Androulakis, M; Giamarellou, H; Goumas, P; Petrikkos, G | 1 |
Bourgault, AM; Horn, R; Lamothe, F | 1 |
Eley, A; Greenwood, D | 2 |
Carson, PB; Moritz, VA | 1 |
Fijalkowski, C; Lacroix, JM; Lamothe, F; Malouin, F | 1 |
Avanzini, P; Bigi, M; Chezzi, C; Lecchini, R; Menozzi, M | 1 |
Hashizume, T; Sawai, T; Yamaguchi, A | 1 |
Brister, S; Brown, RA; Chiu, RC; Fradet, G; Mulder, DS; Prentis, J; Richards, GK | 1 |
Howell, AW; Jorgensen, JH; Redding, JS | 1 |
Poindexter, AN; Ritter, M; Sweet, R | 1 |
Connors, JE; Donaldson, ES; Hager, WD; Rapp, RP; van Nagell, JR | 1 |
McGregor, JA | 1 |
Barza, M; Gorbach, SL; Ho, JL; Kellum, JM; O'Donnell, TF; Tally, FP | 1 |
Brown, RB; Klar, J; Lemeshow, S; Pastides, H; Sands, M; Teres, D | 1 |
Bitondo, CG; Burch, JM; Cruse, PA; Feliciano, DV; Gentry, LO; Jordan, GL; Mattox, KL | 1 |
Berche, P; Gaillard, JL | 1 |
Carter, WT; Finegold, SM; Harris, BH; Wexler, H | 1 |
Chin, NX; Labthavikul, P; Neu, HC | 1 |
Ben Yaghlane, H; Bryskier, A; Labia, R; Morand, A | 1 |
Citron, DM; Goldstein, EJ | 1 |
Mandell, GL | 1 |
Raff, MJ; Schupp, LG; Summersgill, JT | 1 |
McNamara, BT; Meyer, RD; Pasiecznik, KA | 1 |
Klastersky, J; Lagast, H | 1 |
Brown, RA; Chou, S; Richards, GK | 1 |
Gadebusch, HH; Shungu, DL; Weinberg, E | 1 |
Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
Durack, DT; Edwards, DJ; Lang, SD | 1 |
Lareng, MB; Lefèvre, JC; Prère, MF | 1 |
Durosoir, JL; Saliou, P; Thabaut, A | 1 |
Armengaud, M; Barza, M; Cherubin, CE; Corrado, ML; Landesman, SH; Shah, PM | 1 |
Fu, KP; Neu, HC | 1 |
Forsgren, A | 1 |
Baumgärtner, M; Dickgiesser, N; Müller, S; Wundt, W | 1 |
Gootz, TD; Martin, RR; Moellering, RC; Perkins, RL; Sanders, CC; Sanders, WE; Strike, DG | 1 |
Labthavikul, P; Neu, HC | 1 |
Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
Gillissen, G | 1 |
Bergeron, MG; Simard, P | 1 |
Knothe, H | 1 |
Barry, AL; Jones, RN; Thornsberry, C | 1 |
Neu, HC | 1 |
Asahi, Y; Isono, M; Kesado, T; Ueno, K; Watanabe, K | 1 |
Jones, RN; Wilson, HW | 1 |
Antsaklis, A; Aravantinos, D; Daikos, GK; Gazis, J; Giamarellou, H; Petrikkos, G | 1 |
Kabins, SA; Levin, MH; Weinstein, RA | 1 |
Ericsson, CD; Rowlands, BJ | 1 |
Alvarez, S; DeMaria, A; Klein, JO; McCabe, WR | 1 |
Bulger, RR; Washington, JA | 1 |
Crokaert, F; Labbé, M; Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
Tally, FP | 1 |
Chandrasekar, PH; Chokkavelu, V; Kannangara, DW; Le Frock, JL; Rolston, KV | 1 |
Amsel, R; Eschenbach, DA; Holmes, KK; Spiegel, CA | 1 |
Hammann, R; Kuchenbecker, K; Werner, H | 2 |
Beadle, BM; Nicholas, RA; Shoichet, BK | 1 |
Casin, I; Felten, A; Grandry, B; Lagrange, PH | 1 |
Abachin, E; Berche, P; Carbonnelle, E; Clauser, S; Ferroni, A; Guillet, C; Jais, JP; Join-Lambert, OF; Kayal, S; Le Monnier, A; Quesnes, G; Zahar, JR | 1 |
Denis, O; Nonhoff, C; Roisin, S; Struelens, MJ | 1 |
Aslan, V; Bahar Erdem, G; Çağatay, M; Mert, A; Özel, G; Sencan, I | 1 |
Anh, NQ; Kirikae, T; Miyoshi-Akiyama, T; Nhung, PH; Ohmagari, N; Phuong, DM; Shimada, K; Tada, T | 1 |
Bloemberg, GV; Hombach, M; Jost, G | 1 |
1 review(s) available for moxalactam and cefoxitin
Article | Year |
---|---|
Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Blood-Brain Barrier; Cefamandole; Cefotaxime; Cefoxitin; Cephaloridine; Cephalosporins; Cephalothin; Cephamycins; Child, Preschool; Enterobacteriaceae; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Middle Aged; Moxalactam; Pseudomonas aeruginosa | 1981 |
11 trial(s) available for moxalactam and cefoxitin
Article | Year |
---|---|
Cephalosporin therapy in intra-abdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
Topics: Cefotetan; Cefoxitin; Drug Evaluation; Humans; Moxalactam; Peritonitis; Random Allocation | 1988 |
Analysis of prothrombin time prolongation in North American cefotetan clinical trials: questions and answers.
Topics: Cefotetan; Cefoxitin; Ceftriaxone; Cephamycins; Clinical Trials as Topic; Humans; Hypoprothrombinemias; Moxalactam; Prothrombin Time | 1988 |
Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections.
Topics: Adult; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Female; Genital Diseases, Female; Humans; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Random Allocation | 1988 |
Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin.
Topics: Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Humans; Moxalactam; Peritonitis; Prospective Studies; Random Allocation; Time Factors | 1988 |
A comparative study of cefoxitin, cefotaxime, moxalactam and aztreonam kinetics in saliva.
Topics: Aztreonam; Cefotaxime; Cefoxitin; Humans; Moxalactam; Saliva | 1987 |
Cefotetan in the treatment of obstetric and gynecologic infections.
Topics: Adult; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Drug Tolerance; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Random Allocation | 1986 |
Comparison of single-dose moxalactam and a three-dose regimen of cefoxitin for prophylaxis in vaginal hysterectomy.
Topics: Adult; Bacteria, Aerobic; Bacteria, Anaerobic; Cefoxitin; Clinical Trials as Topic; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Premedication; Random Allocation; Surgical Wound Infection | 1986 |
Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Surgical Wound Infection; Tobramycin | 1986 |
Single agent cephalosporin prophylaxis for penetrating abdominal trauma. Results and comment on the emergence of the enterococcus.
Topics: Abdominal Injuries; Adult; Cefotaxime; Cefoxitin; Drug Evaluation; Female; Humans; Male; Moxalactam; Postoperative Complications; Prospective Studies; Random Allocation; Wound Infection; Wounds and Injuries | 1986 |
Anaerobic infections in cancer patients--a retrospective analysis of clindamycin, tinidazole, doxycycline, cefoxitin and lamoxactam.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoxitin; Cephamycins; Clindamycin; Clinical Trials as Topic; Doxycycline; Drainage; Female; Humans; Male; Middle Aged; Moxalactam; Neoplasms; Retrospective Studies; Tinidazole | 1982 |
Comparative studies of antibiotic therapy after penetrating abdominal trauma.
Topics: Abdominal Injuries; Adolescent; Cefoxitin; Cephalosporins; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Moxalactam; Premedication; Prospective Studies; Random Allocation; Time Factors; Tobramycin; Wound Infection; Wounds, Gunshot; Wounds, Stab | 1984 |
70 other study(ies) available for moxalactam and cefoxitin
Article | Year |
---|---|
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cloning, Molecular; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology | 2010 |
Detection of antibiotic-induced platelet dysfunction in whole blood using flow cytometry.
Topics: Adenosine Diphosphate; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Blood Platelet Disorders; Cefotetan; Cefoxitin; Epinephrine; Flow Cytometry; Fluorescein; Fluoresceins; Goats; Humans; Immunoglobulin G; Mice; Moxalactam; P-Selectin; Platelet Activation; Platelet Membrane Glycoproteins; Tetrazoles | 1992 |
[Determination of the MIC of cefotetan against freshly isolated gram-negative bacilli].
Topics: Cefazolin; Cefmetazole; Cefotetan; Cefoxitin; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Moxalactam | 1989 |
[Action of imipenem on Enterobacter cloacae].
Topics: Cefotaxime; Cefoxitin; Ceftazidime; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Imipenem; Moxalactam; Penicillin Resistance; Phenotype; Piperacillin; Thienamycins | 1988 |
In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Cefotaxime; Cefoxitin; Cephalosporins; Clindamycin; Clostridium; Moxalactam; Peptococcaceae; Propionibacterium acnes | 1988 |
Disk diffusion susceptibility testing of the Bacteroides fragilis group.
Topics: Bacteroides fragilis; Cefoxitin; Chloramphenicol; Clindamycin; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins; Ticarcillin | 1987 |
Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Cephalosporins; Drug Resistance, Microbial; Imipenem; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Moxalactam; Nephelometry and Turbidimetry; Thienamycins | 1986 |
Cefoxitin sensitivity as a marker for inducible beta-lactamases.
Topics: beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Gram-Negative Bacteria; Microbial Sensitivity Tests; Moxalactam; Pseudomonas | 1986 |
Inactivation of cefoxitin and moxalactam by Bacteroides bivius beta-lactamase.
Topics: Bacteroides; beta-Lactamases; Biological Assay; Cefoxitin; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Spectrophotometry, Ultraviolet | 1986 |
In vitro antibacterial activity of cefotetan against Bacteroides fragilis group clinical isolates.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefotetan; Cefoxitin; Humans; Kinetics; Microbial Sensitivity Tests; Microscopy, Electron; Moxalactam | 1987 |
Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cell Membrane Permeability; Citrobacter; Cloxacillin; Enterobacter; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins | 1986 |
Antibiotic prophylaxis in vascular surgery: pharmacokinetic study of four commonly used cephalosporins.
Topics: Animals; Aorta; Bacterial Infections; Cefamandole; Cefazolin; Cefoxitin; Cephalosporins; Dogs; Escherichia coli Infections; Kinetics; Moxalactam; Muscles; Staphylococcal Infections; Time Factors; Tissue Distribution; Vascular Surgical Procedures | 1986 |
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroidaceae; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Ceftizoxime; Clostridium; Evaluation Studies as Topic; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1986 |
Enhanced bleeding with cefoxitin or moxalactam: statistical analysis within a defined population of 1493 patients.
Topics: Cefoxitin; Hemorrhage; Humans; Moxalactam; Postoperative Complications | 1987 |
Enhanced bleeding with cefoxitin or moxalactam. Statistical analysis within a defined population of 1493 patients.
Topics: Anti-Bacterial Agents; Cefoxitin; Female; Hemorrhage; Humans; Male; Middle Aged; Moxalactam; Regression Analysis | 1986 |
[In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
Topics: Cefotaxime; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Moxalactam; Species Specificity | 1986 |
In vitro activity of cefbuperazone against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoxitin; Cephamycins; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Piperacillin | 1985 |
The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
Topics: Bacteria; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephamycins; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1985 |
Behaviour of cefmenoxime towards beta-lactamases.
Topics: beta-Lactamases; Cefmenoxime; Cefotaxime; Cefoxitin; Computers; Enterobacter; Escherichia coli; Kinetics; Klebsiella; Moxalactam; Proteus vulgaris; Pseudomonas aeruginosa | 1985 |
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.
Topics: Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Cross Infection; Hospitals, Community; Humans; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1985 |
In vitro microbiology and pharmacokinetics of piperacillin.
Topics: Adult; Cefoxitin; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Kidney; Kinetics; Moxalactam; Piperacillin | 1985 |
Comparative penetration of metronidazole, clindamycin, chloramphenicol, cefoxitin, ticarcillin, and moxalactam into bone.
Topics: Animals; Anti-Infective Agents; Bone and Bones; Cefoxitin; Cephamycins; Chloramphenicol; Clindamycin; Metronidazole; Moxalactam; Rats; Rats, Inbred Strains; Ticarcillin; Time Factors | 1982 |
In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cephalothin; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1982 |
A new approach to antibiotic therapy in colon surgery based on bioassay tissue concentrations.
Topics: Animals; Anti-Bacterial Agents; Cefoxitin; Cephamycins; Clindamycin; Colon; Dogs; Enterocolitis, Pseudomembranous; Granulation Tissue; Metronidazole; Moxalactam; Premedication; Surgical Wound Infection; Tissue Distribution | 1982 |
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Blood; Cefoxitin; Ceftazidime; Cephalosporins; Culture Media; Evaluation Studies as Topic; Humans; Imipenem; Moxalactam; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Sulfhydryl Compounds; Thienamycins; Urine | 1984 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Topics: Aerobiosis; Bacteria; Blood; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Culture Media; Drug Resistance, Microbial; Humans; Moxalactam; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus | 1980 |
Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
Topics: Ampicillin; Cefazolin; Cefotaxime; Cefotiam; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Cephamycins; Female; France; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillins | 1981 |
Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Topics: Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Neisseria meningitidis | 1981 |
Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
Topics: Bacteroides fragilis; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Cephamycins; In Vitro Techniques; Moxalactam | 1981 |
Comparative in vitro activity of first, second and third generation cephalosporins.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Structure-Activity Relationship | 1981 |
[Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Topics: Bacteria; Cefazolin; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam | 1981 |
Resistance to cefamandole: a collaborative study of emerging clinical problems.
Topics: Adult; Aged; Bacteroides Infections; beta-Lactamases; Cefamandole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Isoelectric Focusing; Male; Middle Aged; Moxalactam; Penicillin Resistance; Penicillins | 1982 |
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1982 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
Non-specific influence of antibiotics on the course of infectious processes.
Topics: Animals; Anti-Bacterial Agents; Antibody Formation; Candidiasis; Cefotaxime; Cefoxitin; Cephamycins; Cyclophosphamide; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Infections; Male; Mice; Mice, Inbred BALB C; Moxalactam; Theophylline | 1982 |
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Cephamycins; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam | 1982 |
[In-vitro activity of cefotaxime].
Topics: Cefotaxime; Cefoxitin; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Streptococcal Infections; Streptococcus | 1983 |
Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Topics: Acinetobacter; Bacteria; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cell Membrane Permeability; Drug Resistance, Microbial; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam; Neisseria; Pseudomonas; Staphylococcus aureus; Streptococcus | 1983 |
Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporinase; Gram-Negative Bacteria; Moxalactam; Penicillinase; Piperacillin | 1983 |
Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamases; Cefmetazole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam | 1984 |
Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Cefotetan; Cefoxitin; Ceftriaxone; Cell Membrane Permeability; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1983 |
A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancy.
Topics: Adult; Amniotic Fluid; Cefoxitin; Ceftazidime; Cephalosporins; Female; Humans; Kinetics; Maternal Age; Maternal-Fetal Exchange; Moxalactam; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second | 1983 |
Cefoxitin disc induction of latamoxef (moxalactam) resistance.
Topics: Bacteriological Techniques; Cefamandole; Cefoxitin; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Moxalactam; Mutation | 1983 |
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
Topics: Amikacin; Ampicillin; Carbenicillin; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Clindamycin; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Haemophilus influenzae; Moxalactam; Oxacillin | 1980 |
Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.
Topics: beta-Lactamases; Cefoperazone; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Haemophilus; Haemophilus influenzae; Humans; Moxalactam | 1980 |
The effect of beta-lactam antibiotics on the growth curves of Bacteroides fragilis, obtained with the MS-2 system.
Topics: Anaerobiosis; Bacteroides fragilis; beta-Lactams; Carbenicillin; Cefoxitin; Cell Division; Cephamycins; Dose-Response Relationship, Drug; Kinetics; Microbial Sensitivity Tests; Moxalactam; Penicillin G | 1981 |
Therapeutic approaches to anaerobic infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cefoxitin; Cephamycins; Chloramphenicol; Clindamycin; Drug Combinations; Female; Gastrointestinal Diseases; Genital Diseases, Female; Gram-Negative Anaerobic Bacteria; Humans; Male; Moxalactam; Respiratory Tract Infections; Skin Diseases, Infectious; Suppuration; Ticarcillin | 1981 |
Comparative efficacy of four antibiotics in anaerobic pulmonary infection. An experimental model in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Eubacterium; Fusobacterium Infections; Male; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Peptococcus; Pneumonia; Rabbits | 1984 |
Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy.
Topics: Adolescent; Adult; Cefoxitin; Clindamycin; Drug Resistance, Microbial; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Moxalactam; Vagina; Vaginitis; Vancomycin; Vibrio; Vibrio Infections | 1983 |
[Anaerobic effect of tinidazol compared with metronidazol, ornidazol, cefoxitin and lamoxactam].
Topics: Bacteria, Anaerobic; Cefoxitin; Metronidazole; Microbial Sensitivity Tests; Moxalactam; Nitroimidazoles; Ornidazole; Tinidazole | 1983 |
[Efficacy of tinidazole against anaerobes in comparison with metronidazole, ornidazole, cefoxitin and lamoxactam].
Topics: Bacteria, Anaerobic; Cefoxitin; Drug Resistance, Microbial; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Metronidazole; Moxalactam; Nitroimidazoles; Ornidazole; Species Specificity; Tinidazole | 1983 |
Variations in susceptibility to latamoxef(moxalactam) and cefoxitin within the Bacteroides fragilis group.
Topics: Bacteroides fragilis; Cefoxitin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Moxalactam; Nephelometry and Turbidimetry; Species Specificity | 1984 |
Interaction energies between beta-lactam antibiotics and E. coli penicillin-binding protein 5 by reversible thermal denaturation.
Topics: Acylation; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carrier Proteins; Cefoxitin; Circular Dichroism; Cloxacillin; Escherichia coli; Hexosyltransferases; Imipenem; Models, Chemical; Moxalactam; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Protein Denaturation; Spectrometry, Fluorescence; Temperature; Thermodynamics | 2001 |
Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test.
Topics: Bacterial Proteins; Carrier Proteins; Cefoxitin; Gene Expression Regulation, Bacterial; Hexosyltransferases; Hospitalization; Humans; Lactams; Latex Fixation Tests; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Moxalactam; Muramoylpentapeptide Carboxypeptidase; Oxacillin; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcal Infections; Staphylococcus aureus | 2002 |
Cephalosporin therapy in intraabdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotetan; Cefoxitin; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests; Moxalactam | 1989 |
Comparison of cefoxitin and moxalactam 30 microg disc diffusion methods for detection of methicillin resistance in coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefoxitin; Coagulase; Methicillin Resistance; Microbial Sensitivity Tests; Moxalactam; Penicillin-Binding Proteins; ROC Curve; Staphylococcus; Staphylococcus epidermidis | 2007 |
Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin.
Topics: Anti-Bacterial Agents; Automation; Bacterial Proteins; Belgium; Cefoxitin; DNA, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2008 |
[Comparison of oxacillin, cefoxitin, ceftizoxime, and moxalactam disk diffusion methods for detection of methicillin susceptibility in staphylococci].
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftizoxime; Disk Diffusion Antimicrobial Tests; Humans; Latex Fixation Tests; Methicillin; Moxalactam; Oxacillin; Penicillin-Binding Proteins; Predictive Value of Tests; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus | 2011 |
IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
Topics: beta-Lactamases; Carbapenems; Cefoxitin; Doripenem; Escherichia coli; Meropenem; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Thienamycins | 2015 |
Improved sensitivity for meticillin resistance detection in coagulase-negative staphylococci by moxalactam antibiotic discs or a cefoxitin investigation zone.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cefoxitin; Coagulase; Methicillin Resistance; Microbial Sensitivity Tests; Moxalactam; Sensitivity and Specificity; Staphylococcus | 2016 |